Hepatitis C

Hepatitis C is a deadly viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often exorbitant complications emerge as a result of damage to the liver. It is evaluates that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on growing improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be conceivably cured.

 

  • Recent Advances in Hepatitis C therapy
  • Prevention of HCV reinfection
  • HCV: Direct Acting Antiviral Era
  • Hepatitis C: Epidemiology
  • HCV Kinetic Models and Implications in Drug Development
  • Treatment options in patients who failed DAA regimens

Related Conference of Hepatitis C

January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
March 04-05, 2019

20th World Congress on Gastroenterology

Berlin, Germany
April 24-25, 2019

International conference on Liver and Hepatitis

Budapest, Hungary
May 15-16, 2019

21st World Congress on Advances in Gastroenterology and Hepatology

Mercure Melbourne Albert Park, Melbourne, Australia
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia
October 23-24, 2019

World Congress on Pancreatic Cancer and Liver Diseases

| Radisson Hotel Narita | Tokyo, Japan

Hepatitis C Conference Speakers

Recommended Sessions

Related Journals

Are you interested in